Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life.

ABSTRACT: We followed 54 infants with in utero HIV after initiating very early antiretroviral treatment. At weeks 24 and 48, ≥80% had CD4 ≥1500 cells/mm3 and CD4% ≥25%. Routine Pneumocystis jirovecii pneumonia prophylaxis in the first year of life may not be necessary for all very early treated infants.

Clinical trials registration

NCT02140255.

SUBMITTER: Nelson BS 

PROVIDER: S-EPMC10169385 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature